New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Sabinsa's ForsLean Brand Coleus Forskohlii Extract Not Connected With Product Contamination in Italy

PISCATAWAY, NJ, May 31, 2005 -- Sabinsa Corporation's ForsLean® brand Coleus forskohlii extract is not linked to contaminated Coleus forskohlii products discovered in Italy. According to a recent notice issued by the Italian Regulatory Authority and the Medicines and Healthcare Products Regulatory Agency in the United Kingdom, a handful of adverse drug reaction reports have been filed in association with the use of Coleus forskohlii containing products in Italy. It is not known whether the material itself was contaminated or if the contamination occurred during the manufacturing process. The following companies were listed as suppliers of potentially contaminated material: IndoWorld Trading Coorporation, Alchem International LTD, Galeno SRL and EPO SRL.

"We want to assure our customers that ForsLean is safe for continued use and is in no way associated with contaminated products in Italy," stated Dr. Muhammed Majeed, CEO, Sabinsa Corporation. "ForsLean is backed by more than a decade of clinical research which has confirmed its safety and efficacy, and we maintain our commitment to providing the highest quality, scientifically supported ingredients."

ForsLean is the only Coleus forskohlii extract that is patented for use as a weight management ingredient and that has been verified for potency and tested for safety and toxicity. All clinical and safety data currently available on Coleus forskohlii extract administered orally has been established using Sabinsa's ForsLean brand exclusively. Additionally, Sabinsa thoroughly tests each batch of ForsLean to ensure that it is free of any contaminants.

ForsLean is an extract derived from Coleus forskohlii roots, and the only known plant source of forskolin, a natural compound that has been shown to increase lean body mass and help optimize body composition through cAMP activation. Sabinsa holds U.S. Patent #5,804,596 and European Patent #98 907 537 9 for the use of forskolin as a weight management ingredient and manufactures and supplies various extract strengths for use in a variety of supplements and products. The use of Coleus forskohlii in such applications without it being the ForsLean brand is a violation of these patents. Other international patents are pending. For more information visit

Sabinsa Corporation, founded in 1988, is a manufacturer and supplier of herbal extracts, cosmeceuticals, minerals and specialty fine chemicals.

Sabinsa's mission is to provide alternative and complementary natural products for human nutrition and well-being. Over the past nine years, Sabinsa has brought to market more than 30 standardized botanical extracts and privately funded several clinical studies in conjunction with prestigious institutions in support of these products. With more than 100 scientists working full time conducting ongoing research both in India and the United States, Sabinsa continues to develop and patent phytonutrients for the world market. All products intended for human consumption are certified Kosher. For more information visit

# # #

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.